135 related articles for article (PubMed ID: 12624523)
1. Use of erythropoietin in patients with multiple myeloma.
Egerer G; Harter C; Karthaus M; Ho AD; Goldschmidt H
Onkologie; 2003 Feb; 26(1):80-4. PubMed ID: 12624523
[TBL] [Abstract][Full Text] [Related]
2. [Recombinant erythropoietin (r-HuEPO) in the treatment of anemia in multiple myeloma].
Spicka I; Haber J; Petruzelka L; Kolesková E; Sálková J; Straub J; Zounar R; Klener P
Cas Lek Cesk; 1996 Jul; 135(14):450-3. PubMed ID: 8925545
[TBL] [Abstract][Full Text] [Related]
3. The role of recombinant human erythropoietin in the management of anaemic cancer patients: focus on haematological malignancies.
Osterbor A
Med Oncol; 2000 Nov; 17 Suppl 1():S17-22. PubMed ID: 11188781
[TBL] [Abstract][Full Text] [Related]
4. [Tumor anemia. Overview of the role of human recombinant erythropoietin (r-hu-EPO) in treatment of tumor anemia].
Monnerat C; Leyvraz S
Praxis (Bern 1994); 1999 Jan; 88(5):178-88. PubMed ID: 10067375
[TBL] [Abstract][Full Text] [Related]
5. Anemia in multiple myeloma.
Ludwig H; Pohl G; Osterborg A
Clin Adv Hematol Oncol; 2004 Apr; 2(4):233-41. PubMed ID: 16163188
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin in the treatment of head and neck tumour anaemia.
Oettle H; Riess H; Raguse JD; Bier J; Gath HJ
Int J Oral Maxillofac Surg; 2001 Apr; 30(2):148-55. PubMed ID: 11405451
[TBL] [Abstract][Full Text] [Related]
7. [Effect of treatment with recombinant erythropoietin in patients with multiple myeloma and kidney failure].
Spicka I; Svára F; Novosadová L; Mácel I; Válková V; Sulková S; Merta M; Klener P
Sb Lek; 1997; 98(2):127-33. PubMed ID: 9601805
[TBL] [Abstract][Full Text] [Related]
8. Therapy of anemia in patients with multiple myeloma.
Adam Z; Krahulová M; Spelda S; Vorlícek J; Hejlová N; Hájek R; Tomíska M
Acta Med Austriaca; 1995; 22(4):59-64. PubMed ID: 8835422
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin in the anaemia of multiple myeloma and non-Hodgkin's lymphoma.
San Miguel JF; García-Sanz R
Med Oncol; 1998 Aug; 15 Suppl 1():S29-34. PubMed ID: 9785334
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of treatment of anemia with erythropoietin in patients with multiple myeloma].
Adam Z; Krahulová M; Spelda S; Vorlícek J; Hejlová N; Hájek R; Tomíska M
Vnitr Lek; 1995 Nov; 41(11):767-72. PubMed ID: 8553596
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin has an anti-myeloma effect - a hypothesis based on a clinical observation supported by animal studies.
Mittelman M; Zeidman A; Kanter P; Katz O; Oster H; Rund D; Neumann D
Eur J Haematol; 2004 Mar; 72(3):155-65. PubMed ID: 14962233
[TBL] [Abstract][Full Text] [Related]
12. rHuEPO and improved treatment outcomes: potential modes of action.
Blackwell K; Gascón P; Sigounas G; Jolliffe L
Oncologist; 2004; 9 Suppl 5():41-7. PubMed ID: 15591421
[TBL] [Abstract][Full Text] [Related]
13. Treatment of the anemia of multiple myeloma: the role of recombinant human erythropoietin.
Barlogie B
Semin Hematol; 1993 Oct; 30(4 Suppl 6):25-7. PubMed ID: 8153675
[TBL] [Abstract][Full Text] [Related]
14. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin and chronic lymphocytic leukemia.
Mauro FR; Gentile M; Foa R
Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
[TBL] [Abstract][Full Text] [Related]
16. The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events.
Rosenzweig MQ; Bender CM; Lucke JP; Yasko JM; Brufsky AM
J Pain Symptom Manage; 2004 Feb; 27(2):185-90. PubMed ID: 15157043
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation in Sweden of epoetin beta with intravenous iron supplementation in anaemic patients with lymphoproliferative malignancies not receiving chemotherapy.
Hedenus M; Näsman P; Liwing J
J Clin Pharm Ther; 2008 Aug; 33(4):365-74. PubMed ID: 18613854
[TBL] [Abstract][Full Text] [Related]
18. Anemia and infections in multiple myeloma: supportive therapy.
Cáceres W; Santiago K; Paulo L; Román J
Bol Asoc Med P R; 2009; 101(2):50-2. PubMed ID: 19954102
[TBL] [Abstract][Full Text] [Related]
19. The use of recombinant human erythropoietin in lung transplantation.
End A; Stift A; Ringl H; Inhauser T; Grimm M; Geissler K; Stockenhuber F; Klepetko W
Wien Klin Wochenschr; 1995; 107(6):181-3. PubMed ID: 7732690
[TBL] [Abstract][Full Text] [Related]
20. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
